𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prophyria cutanea tarda and hepatitis C and B viruses infection: A retrospective study

✍ Scribed by Sonia Navas; Orencio Bosch; Inmaculada Castillo; Eduardo Marriott; Vicente Carreño


Book ID
102851039
Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
625 KB
Volume
21
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Based on the knowledge that patients with porphyria A common characteristic of patients with PCT is liver cutanea tarda (PCT) usually have chronic liver disease, dy~function.~ However, great variation has been obseveral authors studied a possible relationship to hepa-served in the degree of liver disease associated with totropic virus infections. However, the prevalence of pCTV5 In this respect, a possible relationship with hepahepatitis virus (*WDNA by polymerase reac-totropic viruses has been pointed out. Thus, a strong tion (PCR) in serum of these patients, as well as the association with markers of past hepatitis B virus (HBV) infection was first demonstrated in patients presence of hepatitis C virus (HCW-RNA in paired liver, peripheral blood mononuclear cells (PBMCs), and serum samples in these patients has not been reported. We have with PCT.' A high prevalence Of hepatitis virus studied 34 patients with sporadic PCT. Antibodies (HCV) markers in patients with PCT recently has also against HBV were detected in 91% of the patients, but been dem~nstrated.~ This anti-HCV prevalence is in only 41% of the patients against HBV (P < .01). Viral greater than that found for HBV marker^.


📜 SIMILAR VOLUMES


Porphyria cutanea tarda and hepatitis C
✍ Tsukazaki; Watanabe; Irifune 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB

We studied the prevalence of hepatitis C virus (HCV) infection in 20 Japanese patients with sporadic-type porphyria cutanea tarda (PCT). Seventeen of the 20 patients (85%) had anti-HCV antibodies. Biochemical remission was observed in nine patients, six of whom still had positive HCV RNA copies. The